Paper Details

  1. Home
  2. Paper Details

Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.

Author: ArvisPierre, BregaNicoletta, CasanovaMichela, DemetriGeorge D, DowlatiAfshin, DrilonAlexander, HongDavid S, KeedyVicki L, KummarShivaani, LassenUlrik N, LeyvrazSerge, LiuTianshu, MallickAtrayee Basu, McDermottRay, MelcónSoledad Gallego, MorenoVictor, NorenbergRicarda, PatelJyoti, PatilTejas, ShenLin, SousaNuno, TaharaMakoto, TanDaniel S W, ZieglerDavid S

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This subset analysis focuses on the efficacy and safety of larotrectinib, a selective TRK inhibitor, in adult patients with TRK fusion sarcomas.
Paper Details　
Original Abstract of the Article :
Larotrectinib, a first-in-class, highly selective tropomyosin receptor kinase (TRK) inhibitor, has demonstrated efficacy in adult and pediatric patients with various solid tumors harboring NTRK gene fusions. This subset analysis focuses on the efficacy and safety of larotrectinib in an expanded coho...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/cncr.35036

データ提供：米国国立医学図書館（NLM）

Larotrectinib: A Targeted Treatment for TRK Fusion Sarcomas

This research examines the efficacy and safety of larotrectinib, a targeted therapy for cancers with specific genetic alterations, in adult patients with TRK fusion sarcomas. The study presents an analysis of an expanded cohort of adult patients, demonstrating the effectiveness of larotrectinib in treating this type of cancer. The findings underscore the importance of personalized medicine, tailoring treatment strategies to the specific genetic makeup of the tumor.

Larotrectinib: A Precision Weapon in the Battle Against TRK Fusion Sarcomas

This research highlights the potential of targeted therapies like larotrectinib in treating cancers with specific genetic alterations. It's like having a precision weapon in the battle against cancer, targeting the tumor cells directly and minimizing damage to healthy tissues. The study's findings suggest that larotrectinib can be an effective treatment option for adult patients with TRK fusion sarcomas, potentially offering a new avenue for improved outcomes.

A Targeted Approach to Cancer Treatment

This research underscores the importance of personalized medicine in cancer treatment. It's like finding a map to a hidden oasis in the vast desert of cancer research, guiding clinicians towards a more effective and targeted approach to treatment. The study's findings suggest that larotrectinib can be a powerful tool for treating TRK fusion sarcomas, offering a personalized approach that potentially leads to better outcomes for patients.

Dr. Camel's Conclusion

This research showcases the potential of larotrectinib as a targeted therapy for TRK fusion sarcomas. It's like discovering a hidden oasis in the vast desert of cancer research, offering a promising new approach to treating these challenging tumors. The study's findings are encouraging, potentially leading to more effective and personalized treatment strategies for adult patients with this type of cancer.

Date :
  1. Date Completed 2023-11-06
  2. Date Revised 2023-11-06
Further Info :

Pubmed ID

37769113

DOI: Digital Object Identifier

10.1002/cncr.35036

Related Literature

Article Analysis
・Side Effects of larotrectinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.